Cargando…

A Recombinant RBD-Based Phage Vaccine Report: A Solution to the Prevention of New Diseases?

The safety, inherent immunogenicity, stability, and low-cost production of bacteriophages make them an ideal platform for vaccine development. Most vaccination strategies against COVID-19 have targeted the spike protein of SARS-CoV-2 to generate neutralizing antibodies. P1, a truncated RBD-derived s...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehi, Zahra, Rasaee, Mohammad Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144462/
https://www.ncbi.nlm.nih.gov/pubmed/37112745
http://dx.doi.org/10.3390/vaccines11040833